Featured conditions Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. See more conditions.
Featured conditions
Results filtered:Study status: Open Contact Us for the Latest Status
The purpose of this study is to determine whether the implementation of pre-emptive PGx[HSR1] testing of a panel of clinically relevant PGx markers, to guide the dose and drug selection for 39 commonly prescribed drugs, will result in an overall reduction in the number of clinically relevant drug-genotype associated ADRs which are causally related to the initial drug of inclusion (referred to as ‘index drug’).
The purpose of this study is is to explore strategies to identify patients who may benefit from hemoglobinopathy (HBP) screening during preconception using qualitative analysis. Secondarily, we plan to explore preconception HBP communication and education between providers and patients.